Topics
Glioblastoma | Treatment | Clinical trials | Immune Checkpoint Inhibitors
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Immune Checkpoint Inhibitors
Schonfeld E, Choi J, Tran A, Kim LH, Lim M.
The
landscape of immune checkpoint inhibitor clinical trials in
glioblastoma: A systematic review.
Neurooncol
Adv. 2024 Nov 12;6(1):vdae174. doi:
10.1093/noajnl/vdae174. PMID:
39534539. Review. ˍ
IDHwt
Baskaran AB, Kozel OA, Venkatesh O, Wainwright DA, Sonabend AM,
Heimberger AB, Lukas RV.
Immune
Checkpoint Inhibitors in Glioblastoma IDHwt Treatment: A
Systematic Review.
Cancers
(Basel). 2024 Dec 12;16(24):4148. doi:
10.3390/cancers16244148. PMID:
39766048. Review. ˍ
de Melo SM, Elias Nunes da Silva ME, Torloni MR, Riera R, De Cicco
K, Latorraca CO, Pinto ACPN.
Anti-PD-1
and anti-PD-L1 antibodies for glioma.
Cochrane
Database Syst Rev. 2025 Jan 8;1(1):CD012532. doi:
10.1002/14651858.CD012532.pub2. PMID:
39777725. Meta-analysis˰
ˍ